RADX
Price:
$4.27
Market Cap:
$47.30M
Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions. The company's diverse pipeline features: RAD 204, designed to target PD-L1 for non-small cell lung cancer; RAD 202, aimed at HER2 for breast cancer and other solid tumor types; and two avß6 integrin-targeting agents, RAD 301 (a diagnostic tool for pancreatic ductal adenocarcinoma) and RAD 302 (a therapeutic agent for various cancers...[Read more]
Industry
Biotechnology
IPO Date
2024-12-05
Stock Exchange
NASDAQ
Ticker
RADX
According to Radiopharm Theranostics Limited’s latest financial reports and current stock price. The company's current ROE is -93.08%. This represents a change of 77.40% compared to the average of -52.47% of the last 4 quarters.
The mean historical ROE of Radiopharm Theranostics Limited over the last ten years is 2.09%. The current -93.08% ROE has changed -4545.44% with respect to the historical average. Over the past ten years (40 quarters), RADX's ROE was at its highest in in the June 2021 quarter at 194.54%. The ROE was at its lowest in in the December 2023 quarter at -102.16%.
Average
2.09%
Median
-77.98%
Minimum
-170.50%
Maximum
389.08%
Discovering the peaks and valleys of Radiopharm Theranostics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 118.65%
Maximum Annual ROE = 389.08%
Minimum Annual Increase = -112.38%
Minimum Annual ROE = -170.50%
| Year | ROE | Change |
|---|---|---|
| 2025 | -81.94% | -51.94% |
| 2024 | -170.50% | 118.65% |
| 2023 | -77.98% | 61.83% |
| 2022 | -48.19% | -112.38% |
The current ROE of Radiopharm Theranostics Limited (RADX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-110.14%
5-year avg
2.09%
10-year avg
2.09%
Radiopharm Theranostics Limited’s ROE is greater than Alaunos Therapeutics, Inc. (-165.94%), greater than Impact BioMedical Inc. (-2674.57%), greater than Quoin Pharmaceuticals, Ltd. (-292.33%), less than NovaBay Pharmaceuticals, Inc. (1.72%), less than Brainstorm Cell Therapeutics Inc. (109.21%), greater than Cardio Diagnostics Holdings, Inc. (-78.82%), greater than Addex Therapeutics Ltd (-102.62%), greater than Matinas BioPharma Holdings, Inc. (-204.27%), greater than Pasithea Therapeutics Corp. (-57.44%), greater than Cyclerion Therapeutics, Inc. (-62.10%),
| Company | ROE | Market cap |
|---|---|---|
| -165.94% | $5.52M | |
| -2674.57% | $7.31M | |
| -292.33% | $8.43M | |
| 1.72% | $39.14M | |
| 109.21% | $8.28M | |
| -78.82% | $4.06M | |
| -102.62% | $4.65M | |
| -204.27% | $4.33M | |
| -57.44% | $4.40M | |
| -62.10% | $14.07M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Radiopharm Theranostics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Radiopharm Theranostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Radiopharm Theranostics Limited's ROE?
How is the ROE calculated for Radiopharm Theranostics Limited (RADX)?
What is the highest ROE for Radiopharm Theranostics Limited (RADX)?
What is the 3-year average ROE for Radiopharm Theranostics Limited (RADX)?
What is the 5-year average ROE for Radiopharm Theranostics Limited (RADX)?
How does the current ROE for Radiopharm Theranostics Limited (RADX) compare to its historical average?